Announced details
Medical and healthcare fields, including telemedicine, occupational physician consultations, health screening facilities, and brain health checkups
Depressive symptoms are assessed based on approximately 10 minutes of open-ended conversation between a patient and a healthcare professional.
Jointly developed by FRONTEO and Keio University School of Medicine.
Located in Shinjuku-ku, Tokyo. The group is led by Professor Taishiro Kishimoto (岸本泰士郎) and others at the Center for Promoting Collaboration in Medical Sciences.
Patent Nos. 7807764 and 7807765. Registration date: 20 January 2026. Expiration date: Not disclosed
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Japan's Ministry of Health, Labour and Welfare; WHO (World Health Organization); Harvard Medical School; World Mental Health Japan Survey
| Item | Details |
|---|---|
| Names of Products / Services Covered | Conversational AI programs designed to support depression diagnosis (depressive symptom assessment device, assessment model generation device, and training data generation method) |
| Counterparty | Keio University School of Medicine |
| Counterparty overview | Located in Shinjuku-ku, Tokyo. The group is led by Professor Taishiro Kishimoto (岸本泰士郎) and others at the Center for Promoting Collaboration in Medical Sciences. |
| Relationship with the Company | Jointly developed by FRONTEO and Keio University School of Medicine. |
| Applicable area | Medical and healthcare fields, including telemedicine, occupational physician consultations, health screening facilities, and brain health checkups |
| Registration number and expiry date | Patent Nos. 7807764 and 7807765. Registration date: 20 January 2026. Expiration date: Not disclosed |
| Quantitative Effects | Depressive symptoms are assessed based on approximately 10 minutes of open-ended conversation between a patient and a healthcare professional. |
| Source | Japan's Ministry of Health, Labour and Welfare; WHO (World Health Organization); Harvard Medical School; World Mental Health Japan Survey |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To enable the early diagnosis and treatment of depression, secure objective evidence for diagnosis, and reduce delays in medical consultations among patients who have not yet sought care.